HealthOn review

What it is

HealthOn is a multi-category telehealth storefront covering weight loss with compounded semaglutide and tirzepatide, sexual health with sildenafil, tadalafil and bremelanotide for men and women, longevity with NAD⁺ injections, an NAD⁺ nasal spray, sermorelin injections and a sermorelin orally dissolving tablet, hair health, and a hormone line including enclomiphene citrate. Care is delivered online with free shipping typically in one to two days. Weight management is one vertical among several rather than a dedicated funnel.

How it works

A Shopify-style storefront wrapped around a telehealth flow, with subscription billing and free fast shipping. Buying peptides from a product grid is efficient and it is also the model where the fewest questions get asked: no live consultation is described in the default path, no lab work appears anywhere, and no baseline bloodwork protocol is disclosed before a growth-hormone-axis compound. The transparency picture is poor across the board. No LegitScript certification or pharmacy accreditation is displayed. No state list is published. No compounding pharmacy is named. And its product template carries another telehealth brand's disclaimer text — a page stating that a different company connects patients with licensed providers — which suggests shared infrastructure and does not inspire confidence in the accuracy of what else is on the page. Given the pricing contradictions below, that last detail stops being trivia.

Pricing transparency

This is where the provider fails on its own terms, and it is not a small failure. Three different figures exist for sermorelin injections on the same site at the same time: the Sexual Health mega-menu advertises a "Sermorelin Injections — Starting at $25/mo" tile above sildenafil, tadalafil and bremelanotide; the sermorelin product page itself says from $155 a month; and the structured product data behind that page says $226. NAD⁺ has the same problem in miniature — the longevity menu advertises NAD⁺ injections starting at $150 a month while the NAD⁺ product page says from $195. We are therefore not quoting a price for either molecule, because there is no single published figure to quote. Before ordering anything, get written confirmation of the monthly price for the specific product and dose, what the billing cycle is, whether any advertised figure is a first-order promotion, and what happens on refill. A sermorelin price displayed inside a sexual-health menu is also a category error worth asking about directly, since sermorelin is a growth-hormone secretagogue and not a sexual-health product.

Branded vs compounded

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate — and that statement is ours rather than the platform's, since it publishes no prominent compounded-medication disclaimer. No compounding pharmacy is named, and compounded sterile products are not FDA-reviewed for purity and potency the way approved drugs are. On the evidence, the longevity and hormone lines span four very different tiers. Sermorelin acts on the growth-hormone axis, a real and well-described mechanism with thin long-term human outcome data and no controlled trial behind the body-composition or anti-aging claims; the orally dissolving tablet route has no comparative bioavailability data published here. Injected and intranasal NAD⁺ have no controlled human outcome trials; oral NR and NMN are the studied forms and they raise a blood level. Bremelanotide is the outlier with genuine randomised human evidence, for hypoactive sexual desire disorder specifically, with a real but modest effect. Enclomiphene has human data on raising endogenous testosterone while preserving fertility markers, but it is not an FDA-approved product for that use and it belongs in a monitored hormone protocol, not a shopping cart. Individual results vary.

Pros and watch-outs

The evidence behind what HealthOn prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• Sermorelin: a real GHRH drug, read against the anti-aging pitch

  An approved growth-hormone-releasing analog with a pediatric track record — and a longevity case built more on biomarkers than outcomes.

• NAD+ precursors (NR and NMN): what the human trials actually show

  They raise NAD+ and look safe short-term — but human evidence is surrogate-marker level, and no trial shows they extend healthspan.

• PT-141 (bremelanotide): the evidence on a research-popular peptide that is actually FDA-approved

  Bremelanotide (Vyleesi) is FDA-approved for HSDD in premenopausal women, with phase-3 trial evidence. A straight read of what's proven — and where off-label use goes beyond it.

• Enclomiphene: the evidence for restoring testosterone without replacing it

  Randomized trials, including two Phase III RCTs, show enclomiphene restores a man's own testosterone while preserving fertility — but it was never FDA-approved.

How HealthOn compares

A few alternatives worth a look, depending on what you’re optimizing for.

• Telos RX

  Choice of GLP-1 formats, including needle-free sublingual tirzepatide

  See Telos RX →
• SLSystem Labs

  NAD⁺ bundled with glutathione, B-12 and sermorelin from one service

  See System Labs →
• LHLuvo Health

  Prescription NAD⁺ as an injection, drops or nasal spray at one flat price

  See Luvo Health →